Publication:
Association between serum cystatin C levels and coronary slow flow.

Simple item page
dc.contributor.authorTasal, Abdurrahman
dc.contributor.authorBacaksiz, Ahmet
dc.contributor.authorErtas, Gokhan
dc.contributor.authorVatankulu, Mehmet Akif
dc.contributor.authorKul, Seref
dc.contributor.authorSari, Soner
dc.contributor.authorDãœz, Muhammed Emin
dc.contributor.authorErdogan, Ercan
dc.contributor.authorSonmez, Osman
dc.contributor.authorGoktekin, Omer
dc.date.accessioned2023-05-16T16:52:09Z
dc.date.available2023-05-16T16:52:09Z
dc.date.issued2014-09-30T21:00:00Z
dc.description.abstractWe assessed the association between serum cystatin C (CysC) levels and coronary slow flow (CSF) phenomenon in patients who underwent coronary angiography. A total of 210 patients (mean age 55.6 ± 10.9 years; 100 females) were included. Patients were divided into 3 groups, (patients with CSF [group 2], with coronary artery disease [CAD; group 3], and without CAD [group 1]). Serum CysC levels in patients with CSF were significantly lower than those with and without CAD (912.5 ± 135.6, 820.4 ± 104.2, and 1343.4 ± 236.6 ng/mL in groups 1, 2, and 3, respectively; P < .001). Serum CysC levels correlated with the number of vessels with CSF and mean corrected thrombolysis in myocardial infarction frame count (Spearman correlation coefficient [r s] = .192, P < .001 and r s = .261, P < .001 respectively). In conclusion, patients with CSF have lower CysC levels; this could be a useful biomarker of CSF involvement in patients who undergo diagnostic coronary angiography.
dc.identifier.pubmed24101711
dc.identifier.urihttps://hdl.handle.net/20.500.12645/38233
dc.language.isoen
dc.subjectcoronary artery disease
dc.subjectcoronary slow flow phenomenon
dc.subjectcystatin C
dc.titleAssociation between serum cystatin C levels and coronary slow flow.
dspace.entity.typePublication
local.indexed.atPubMed

Files

Collections

Pubmed Ek Yayınlar